HealthDay News – Five-year outcomes are similar for patients with coronary artery disease (CAD) who undergo off-pump or on-pump coronary artery bypass grafting (CABG), according to a study published online in the New England Journal of Medicine to coincide with the annual Canadian Cardiovascular Congress, held from October 22 to 25 in Montreal.

André Lamy, MD, from McMaster University in Hamilton, Canada, and colleagues reported the 5-year results of a randomized trial involving 4752 patients with CAD who were randomized to undergo off-pump or on-pump CABG. They analyzed a composite outcome of death, stroke, myocardial infarction, renal failure, or repeat coronary revascularization (CABG or percutaneous coronary intervention).

The researchers found that the rate of the composite outcome did not differ significantly for the off-pump and on-pump groups (23.1% and 23.6%, respectively; hazard ratio with off-pump CABG, 0.98; 95% confidence interval, 0.87-1.10). There was also no significant difference in the rates of the separate components of the outcome. For the overall period of the trial, the secondary outcome of mean cost in US dollars per patient also did not differ between the off-pump and on-pump group ($15,107 and $14,992, respectively).


Continue Reading

“The rate of the composite outcome of death, stroke, myocardial infarction, renal failure, or repeat revascularization at five years of follow-up was similar among patients who underwent off-pump CABG and those who underwent on-pump CABG,” the authors wrote.

Reference

Lamy A, Devereaux PJ, Prabhakaran D, et al; for the CORONARY Investigators. Five-year outcomes after off-pump or on-pump coronary artery bypass grafting. N Engl J Med. 2016 Oct 23. doi:10.1056/NEJMoa1601564 [Epub ahead of print].